AVEO Pharmaceuticals gapped up slightly Thursday and has surged higher in early trade on the highest volume in 2 1/2 months. The stock has soared to a new high for the year.
Realtime Business News · 5/21/2015
IsoRay (NYSE: ISR) 35.4% HIGHER; Cesium-131 Lung Cancer Treatment Reports 96% Success in Local Control and 100% Survival at 5 Years in High Risk Patients in Newly Published Report AVEO Pharmaceuticals …
StreetInsider · 5/20/2015
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) shares touched a new 52-week high of $2.91. On Wednesday, the company reported final results from its TIVO-1 extension study.
Benzinga · ByLisa Levin · 5/21/2015
More from Bing News
Download this announcement via the 'Download' link above instead. Two of Australia's highest performing fund managers have warned investors that the good times for the big banking stocks are coming to an end.
Sydney Morning Herald · 5/21/2015
AVEO Pharmaceuticals, Inc. (AVEO) was a big mover last session, as its shares rose over 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally breaks the recent trend for …
Yahoo Finance · 4/17/2015
Stocks were holding on to slim gains Thursday afternoon ... The iShares Silver Trust was up 0.18% to $16.40. (+) AVEO (+50.63%) Continues to rally on renal cancer study results (+) IPCI (+16.61%) FDA says no phase III studies needed for Rexista …
NASDAQ · 5/22/2015
It's got a couple more drugs in the pipeline too, however, all of them built on AVEO's proprietary Human Response Platform(tm). It's nothing about the pipeline today, however, that's spurring the stock higher... at least not directly. Indirectly ...
Smallcap Network · ByJames E. Brumley · 4/17/2015
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday ... Wagner Jr. will resign and take a position at Ortho-Clinical Diagnostics. AVEO Pharmaceuticals Inc., up 63 cents to $2.23 The biotechnology company reported positive final ...
Rapid City Journal · 5/21/2015
Here is a curious chain of events. On May 18, 2012, Ronald DePinho, who co-founded Aveo Pharmaceuticals (AVEO) and was a board member at the time, touted the stock on CNBC. But just 11 days earlier, his wife, Lynda Chin, who is another co-founder …
YCharts · 9/16/2013
Aveo Pharmaceuticals (Nasdaq: AVEO) saw its stock rise more than 13 percent on Thursday after the company announced its first profitable quarter, and the extension of a cancer drug trial that could mean that patients are living longer on Aveo’s drug ...
The Business Journal · ByJulie M. Donnelly · 4/28/2011
Related Searches